In addition to the reduction in ADAMTS13, anti-ADAMTS13 antibodies and ultra-large VWF multimers can be detected in TTP patients who are in remission [31, 32]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.